-
1
-
-
0035281688
-
Localization of endostatin in rat and human gliomas
-
Strik HM, Schluesener HJ, Seid K, Meyermann R, Deininger MH. Localization of endostatin in rat and human gliomas. Cancer 2001 91 : 1013 1019.
-
(2001)
Cancer
, vol.91
, pp. 1013-1019
-
-
Strik, H.M.1
Schluesener, H.J.2
Seid, K.3
Meyermann, R.4
Deininger, M.H.5
-
2
-
-
0028870050
-
Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: Implications for tumor angiogenesis
-
Shweiki D, Neeman M, Itin A, Keshet E. Induction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesis. Proc Natl Acad Sci USA 1995 92 : 768 772.
-
(1995)
Proc Natl Acad Sci USA
, vol.92
, pp. 768-772
-
-
Shweiki, D.1
Neeman, M.2
Itin, A.3
Keshet, E.4
-
3
-
-
0031454617
-
Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
-
O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997 88 : 277 285.
-
(1997)
Cell
, vol.88
, pp. 277-285
-
-
O'Reilly, M.S.1
Boehm, T.2
Shing, Y.3
Fukai, N.4
Vasios, G.5
Lane, W.S.6
-
4
-
-
0027970092
-
Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
-
O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 1994 79 : 315 328.
-
(1994)
Cell
, vol.79
, pp. 315-328
-
-
O'Reilly, M.S.1
Holmgren, L.2
Shing, Y.3
Chen, C.4
Rosenthal, R.A.5
Moses, M.6
-
5
-
-
0034653421
-
Secreted cathepsin L generates endostatin from collagen XVIII
-
Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W. Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 2000 19 : 1187 1194.
-
(2000)
EMBO J
, vol.19
, pp. 1187-1194
-
-
Felbor, U.1
Dreier, L.2
Bryant, R.A.3
Ploegh, H.L.4
Olsen, B.R.5
Mothes, W.6
-
6
-
-
0034672644
-
Generation and degradation of human endostatin proteins by various proteinases
-
Ferreras M, Felbor U, Lenhard T, Olsen BR, Delaisse J. Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett 2000 486 : 247 251.
-
(2000)
FEBS Lett
, vol.486
, pp. 247-251
-
-
Ferreras, M.1
Felbor, U.2
Lenhard, T.3
Olsen, B.R.4
Delaisse, J.5
-
7
-
-
0033572338
-
The generation of endostatin is mediated by elastase
-
Wen W, Moses MA, Wiederschain D, Arbiser JL, Folkman J. The generation of endostatin is mediated by elastase. Cancer Res 1999 59 : 6052 6056.
-
(1999)
Cancer Res
, vol.59
, pp. 6052-6056
-
-
Wen, W.1
Moses, M.A.2
Wiederschain, D.3
Arbiser, J.L.4
Folkman, J.5
-
8
-
-
0033542129
-
Cloning, expression, and in vitro activity of human endostatin
-
Dhanabal M, Volk R, Ramchandran R, Simons M, Sukhatme VP. Cloning, expression, and in vitro activity of human endostatin. Biochem Biophys Res Commun 1999 258 : 345 352.
-
(1999)
Biochem Biophys Res Commun
, vol.258
, pp. 345-352
-
-
Dhanabal, M.1
Volk, R.2
Ramchandran, R.3
Simons, M.4
Sukhatme, V.P.5
-
9
-
-
0032892179
-
Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene
-
DOI 10.1038/7895
-
Blezinger P, Wang J, Gondo M, Quezada A, Mehrens D, French M, et al. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene. Nat Biotechnol 1999 17 : 343 348. (Pubitemid 29166035)
-
(1999)
Nature Biotechnology
, vol.17
, Issue.4
, pp. 343-348
-
-
Blezinger, P.1
Wang, J.2
Gondo, M.3
Quezada, A.4
Mehrens, D.5
French, M.6
Singhal, A.7
Sullivan, S.8
Rolland, A.9
Ralston, R.10
Min, W.11
-
10
-
-
18844467502
-
Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis
-
Kaya M, Wada T, Akatsuka T, Kawaguchi S, Nagoya S, Shindoh M, et al. Vascular endothelial growth factor expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis. Clin Cancer Res 2000 6 : 572 577.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 572-577
-
-
Kaya, M.1
Wada, T.2
Akatsuka, T.3
Kawaguchi, S.4
Nagoya, S.5
Shindoh, M.6
-
11
-
-
0033166894
-
Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma
-
Lee YH, Tokunaga T, Oshika Y, Suto R, Yanagisawa K, Tomisawa M, et al. Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma. Eur J Cancer 1999 35 : 1089 1093.
-
(1999)
Eur J Cancer
, vol.35
, pp. 1089-1093
-
-
Lee, Y.H.1
Tokunaga, T.2
Oshika, Y.3
Suto, R.4
Yanagisawa, K.5
Tomisawa, M.6
-
12
-
-
0020059356
-
Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy
-
Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 1982 49 : 1221 1230.
-
(1982)
Cancer
, vol.49
, pp. 1221-1230
-
-
Rosen, G.1
Caparros, B.2
Huvos, A.G.3
Kosloff, C.4
Nirenberg, A.5
Cacavio, A.6
-
13
-
-
33947693893
-
Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer
-
Zlobec I, Minoo P, Baker K, Haegert D, Khetani K, Tornillo L, et al. Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer. Eur J Cancer 2007 43 : 1101 1107.
-
(2007)
Eur J Cancer
, vol.43
, pp. 1101-1107
-
-
Zlobec, I.1
Minoo, P.2
Baker, K.3
Haegert, D.4
Khetani, K.5
Tornillo, L.6
-
14
-
-
33747624927
-
Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer
-
Zlobec I, Steele R, Michel RP, Compton CC, Lugli A, Jass JR. Scoring of p53, VEGF, Bcl-2 and APAF-1 immunohistochemistry and interobserver reliability in colorectal cancer. Mod Pathol 2006 19 : 1236 1242.
-
(2006)
Mod Pathol
, vol.19
, pp. 1236-1242
-
-
Zlobec, I.1
Steele, R.2
Michel, R.P.3
Compton, C.C.4
Lugli, A.5
Jass, J.R.6
-
15
-
-
0035871306
-
Serum endostatin levels are elevated in patients with soft tissue sarcoma
-
Feldman AL, Pak H, Yang JC, Alexander HR Jr., Libutti SK. Serum endostatin levels are elevated in patients with soft tissue sarcoma. Cancer 2001 91 : 1525 1529.
-
(2001)
Cancer
, vol.91
, pp. 1525-1529
-
-
Feldman, A.L.1
Pak, H.2
Yang, J.C.3
Alexander, Jr.H.R.4
Libutti, S.K.5
-
16
-
-
0025141337
-
What is the evidence that tumors are angiogenesis dependent?
-
Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990 82 : 4 6.
-
(1990)
J Natl Cancer Inst
, vol.82
, pp. 4-6
-
-
Folkman, J.1
-
17
-
-
0037317037
-
Postoperative progression of pulmonary metastasis in osteosarcoma
-
Tsunemi T, Nagoya S, Kaya M, Kawaguchi S, Wada T, Yamashita T, et al. Postoperative progression of pulmonary metastasis in osteosarcoma. Clin Orthop Relat Res 2003 407 : 159 166.
-
(2003)
Clin Orthop Relat Res
, vol.407
, pp. 159-166
-
-
Tsunemi, T.1
Nagoya, S.2
Kaya, M.3
Kawaguchi, S.4
Wada, T.5
Yamashita, T.6
-
18
-
-
34547460760
-
Endostatin gene variation and protein levels in breast cancer susceptibility and severity
-
Balasubramanian SP, Cross SS, Globe J, Cox A, Brown NJ, Reed MW. Endostatin gene variation and protein levels in breast cancer susceptibility and severity. BMC Cancer 2007 7 : 107.
-
(2007)
BMC Cancer
, vol.7
, pp. 107
-
-
Balasubramanian, S.P.1
Cross, S.S.2
Globe, J.3
Cox, A.4
Brown, N.J.5
Reed, M.W.6
-
19
-
-
0037110699
-
Serum endostatin predicts tumor vascularity in hepatocellular carcinoma
-
Dhar DK, Ono T, Yamanoi A, Soda Y, Yamaguchi E, Rahman MA, et al. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma. Cancer 2002 95 : 2188 2195.
-
(2002)
Cancer
, vol.95
, pp. 2188-2195
-
-
Dhar, D.K.1
Ono, T.2
Yamanoi, A.3
Soda, Y.4
Yamaguchi, E.5
Rahman, M.A.6
-
20
-
-
0036718370
-
Increased levels of tissue endostatin in human malignant gliomas
-
Morimoto T, Aoyagi M, Tamaki M, Yoshino Y, Hori H, Duan L, et al. Increased levels of tissue endostatin in human malignant gliomas. Clin Cancer Res 2002 8 : 2933 2938.
-
(2002)
Clin Cancer Res
, vol.8
, pp. 2933-2938
-
-
Morimoto, T.1
Aoyagi, M.2
Tamaki, M.3
Yoshino, Y.4
Hori, H.5
Duan, L.6
-
21
-
-
43049107543
-
Expression pattern and circulating levels of endostatin in patients with pancreas cancer
-
Ohlund D, Ardnor B, Oman M, Naredi P, Sund M. Expression pattern and circulating levels of endostatin in patients with pancreas cancer. Int J Cancer 2008 122 : 2805 2810.
-
(2008)
Int J Cancer
, vol.122
, pp. 2805-2810
-
-
Ohlund, D.1
Ardnor, B.2
Oman, M.3
Naredi, P.4
Sund, M.5
-
22
-
-
0037108103
-
Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma
-
Feldman AL, Alexander HR Jr., Yang JC, Linehan WM, Eyler RA, Miller MS, et al. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma. Cancer 2002 95 : 1637 1643.
-
(2002)
Cancer
, vol.95
, pp. 1637-1643
-
-
Feldman, A.L.1
Alexander, Jr.H.R.2
Yang, J.C.3
Linehan, W.M.4
Eyler, R.A.5
Miller, M.S.6
-
23
-
-
0037845038
-
Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma
-
Bono P, Teerenhovi L, Joensuu H. Elevated serum endostatin is associated with poor outcome in patients with non-Hodgkin lymphoma. Cancer 2003 97 : 2767 2775.
-
(2003)
Cancer
, vol.97
, pp. 2767-2775
-
-
Bono, P.1
Teerenhovi, L.2
Joensuu, H.3
-
24
-
-
0034638790
-
Antibodies to endostatin in a multifocal glioblastoma patient
-
Ratel D, Nasser V, Dupre I, Benabid AL, Berger F. Antibodies to endostatin in a multifocal glioblastoma patient. Lancet 2000 356 : 1656 1657.
-
(2000)
Lancet
, vol.356
, pp. 1656-1657
-
-
Ratel, D.1
Nasser, V.2
Dupre, I.3
Benabid, A.L.4
Berger, F.5
-
25
-
-
1642482608
-
Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer
-
Zhao J, Yan F, Ju H, Tang J, Qin J. Correlation between serum vascular endothelial growth factor and endostatin levels in patients with breast cancer. Cancer Lett 2004 204 : 87 95.
-
(2004)
Cancer Lett
, vol.204
, pp. 87-95
-
-
Zhao, J.1
Yan, F.2
Ju, H.3
Tang, J.4
Qin, J.5
-
26
-
-
0034794547
-
A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases
-
Feldman AL, Alexander HR Jr., Bartlett DL, Kranda KC, Miller MS, Costouros NG, et al. A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases. Ann Surg Oncol 2001 8 : 741 745.
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 741-745
-
-
Feldman, A.L.1
Alexander, Jr.H.R.2
Bartlett, D.L.3
Kranda, K.C.4
Miller, M.S.5
Costouros, N.G.6
-
27
-
-
33751403599
-
Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group
-
Schips L, Dalpiaz O, Lipsky K, Langner C, Rehak P, Puerstner P, et al. Serum levels of vascular endothelial growth factor (VEGF) and endostatin in renal cell carcinoma patients compared to a control group. Eur Urol 2007 51 : 168 173.
-
(2007)
Eur Urol
, vol.51
, pp. 168-173
-
-
Schips, L.1
Dalpiaz, O.2
Lipsky, K.3
Langner, C.4
Rehak, P.5
Puerstner, P.6
-
28
-
-
33744466541
-
Antiangiogenic therapy: A universal chemosensitization strategy for cancer?
-
Kerbel RS. Antiangiogenic therapy: a universal chemosensitization strategy for cancer? Science (New York) 2006 312 : 1171 1175.
-
(2006)
Science (New York)
, vol.312
, pp. 1171-1175
-
-
Kerbel, R.S.1
|